Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
4.915
+0.135 (2.82%)
At close: Jul 8, 2026, 4:00 PM EDT
4.900
-0.015 (-0.31%)
After-hours: Jul 8, 2026, 4:10 PM EDT
Intensity Therapeutics Market Cap
Intensity Therapeutics has a market cap or net worth of $13.28 million as of July 8, 2026. Its market cap has increased by 77.79% in one year.
Market Cap
13.28M
Enterprise Value
2.60M
1-Year Change
77.79%
Ranking
Category
Stock Price
$4.92
Market Cap Chart
Since the IPO on June 30, 2023, Intensity Therapeutics's market cap has decreased from $66.01M to $13.28M, a decrease of -79.88%. That is a compound annual growth rate of -41.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2026 | 13.28M | -46.08% |
| Dec 31, 2025 | 24.64M | -7.32% |
| Dec 31, 2024 | 26.58M | -77.37% |
| Dec 29, 2023 | 117.49M | 77.98% |
| Jun 30, 2023 | 66.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jasper Therapeutics | 13.05M |
| Moleculin Biotech | 12.81M |
| Exicure | 12.68M |
| Curis | 11.87M |
| Traws Pharma | 11.77M |
| Psyence Biomedical | 11.67M |
| Theriva Biologics | 11.62M |
| Phio Pharmaceuticals | 11.50M |